The app runs on the Apple Watch platform and collects biometric data while a user sleeps. Its machine learning algorithms use the data to create a sleep pattern profile, which allows the app to detect the onset of nightmares and use vibrotactile feedback to interrupt the nightmare without fully waking the user or interrupting their circadian sleep rhythm.
The “Breakthrough Status” designation, reserved for therapies for life-threatening conditions with no approved treatments, will expedite NightWare’s ongoing randomized clinical trials, then grant the app priority review for FDA approval.
More articles about AI:
Google Cloud, Informatica expand partnership to make massive datasets more AI-friendly
New AI platform matches patients to the DNA tests best for them
AI links city’s good mood days to risky behaviors
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
